Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 59/100

Termination Rate

14.3%

1 terminated out of 7 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed with results

Key Signals

2 with results80% success

Data Visualizations

Phase Distribution

5Total

Not Applicable (3)

P 1 (1)

P 2 (1)

Trial Status

Completed4

Enrolling By Invitation1

Recruiting1

Terminated1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT04324450Not ApplicableCompletedPrimary

Memory Neuroimaging in Children, Adolescents and Young Adults Following Pediatric Cancer

NCT02045381Completed

Optimization of MRI for Radiation Therapy

NCT06583395Enrolling By Invitation

Quest to Analyze One Thousand Humans Meditating

NCT03561896Not ApplicableCompleted

Hypofractionated Brain Radiationcavity

NCT06418113Phase 1Recruiting

Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma

NCT04646213Not ApplicableCompleted

Managing Cancer and Living Meaningfully

NCT00585221Phase 2Terminated

Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients

Showing all 7 trials

Cancer Brain